References

therapeutic

Южно-Российский журнал терапевтической практики

South Russian Journal of Therapeutic Practice

2712-81563033-8344

РостГМУ

10.21886/2712-8156-2021-2-1-8-16

therapeutic-118

Research Article

ОБЗОРЫ

REVIEWS

Перспективы терапии центрального апноэ сна и дыхания Чейн-Стокса при сердечной недостаточности

Prospects for the treatment of central sleep apnea and Cheyne-Stokes respiration in heart failure

https://orcid.org/0000-0003-3758-5850

Алехина

Ю. В.

Alyokhina

Y. V.

Алехина Юлия Вадимовна - студентка факультета фундаментальной медицины.

Москва

Yulia V. Alyokhina, student of the Fundamental Medicine Faculty.

Moscow

alekhjuliet97@gmail.com

https://orcid.org/0000-0002-1490-2078

Середенина

Е. М.

Seredenina

E. M.

Середенина Елена Михайловна - кандидат медицинских наук, старший научный сотрудник отдела возраст-ассоциированных заболеваний.

Москва

Elena M. Seredenina, Cand. Sci. (Med.), leading researcher of the Department of Age-Related Diseases.

Moscow

e.m.seredenina@gmail.com

https://orcid.org/0000-0002-5324-4733

Калинкин

А. Л.

Kalinkin

A. L.

Калинкин Александр Леонидович - руководитель центра медицины сна, ведущий научный сотрудник отдела воз-раст-ассоциированных заболеваний.

Москва

Alexander L. Kalinkin, Head of the Sleep Medicine Center of the Lomonosov Moscow State University Clinic, leading researcher of the Department of Age-Related Diseases.

Moscow

akalinkin@sleeplab.ru

ФГБОУ ВО Московский государственный университет имени М.В. ЛомоносоваРоссияLomonosov Moscow State UniversityRussian Federation

Медицинский научно-образовательный центр МГУ имени М.В. ЛомоносоваРоссияLomonosov Moscow State University ClinicRussian Federation

2021

23032021

21816

2021

Алехина Ю.В., Середенина Е.М., Калинкин А.Л.

Alyokhina Y.V., Seredenina E.M., Kalinkin A.L.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.therapeutic-j.ru/jour/article/view/118

В этом обзоре обсуждаются факторы риска, клинические проявления, патофизиология, диагностика и варианты лечения центрального апноэ сна и дыхания Чейна-Стокса у пациентов с сердечной недостаточностью. Обсуждаются эффективность и перспективы терапевтических методов, таких как «сипап»-терапия, адаптивная сервовентиляция, трансвенозная стимуляция диафрагмального нерва.

The risk factors, clinical manifestations, pathophysiology, diagnosis and treatment options for central sleep apnea and Cheyne-Stokes respiration in patients with heart failure are highlighted in this review. The effectiveness and prospects of therapeutic approaches are discussed: CPAP therapy, adaptive servo ventilation, transvenous stimulation of the phrenic nerve.

дыхание Чейна-Стоксацентральное апноэ сна«сипап»-терапияадаптивная сервовентиляциятрансвенозная стимуляция диафрагмального нерва

Cheyne-Stokes respirationcentral sleep apneacontinuous positive airway pressure therapyadaptive servo-ventilation therapytransvenous stimulation of the phrenic nerve

References1

Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013;15(7):808-17. DOI: 10.1093/eurjhf/hft050

Brack T. Cheyne-Stokes respiration in patients with congestive heart failure. Swiss Med Wkly. 2003;133(45-46):605-10. PMID: 14745666.

Coniglio AC, Mentz RJ. Sleep Breathing Disorders in Heart Failure. Heart Fail Clin. 2020;16(1):45-51. DOI: 10.1016/j.hfc.2019.08.009

Andreas S, Hagenah G, Moller C, Werner GS, Kreuzer H. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol. 1996;78(11):1260-4. DOI: 10.1016/s0002-9149(96)00608-x

Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996;153(1):272-6. DOI: 10.1164/ajrccm.153.1.8542128

Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99(11):1435-40. DOI: 10.1161/01.cir.99.11.1435

Arzt M, Oldenburg O, Graml A, Erdmann E, Teschler H, We-gscheider K, et al. Phenotyping of Sleep-Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction-the SchlaHF Registry. J Am Heart Assoc. 2017;6(12):e005899. DOI: 10.1161/JAHA.116.005899

Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E, et al. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail. 2016;4(2):116-125. DOI: 10.1016/j.jchf.2015.09.014

Selim BJ, Ramar K. Management of Sleep Apnea Syndromes in Heart Failure. Sleep Med Clin. 2017;12(1):107-121. DOI: 10.1016/j.jsmc.2016.10.004

Dharia SM, Brown LK. Epidemiology of Sleep-Disordered Breathing and Heart Failure: What Drives What. Curr Heart Fail Rep. 2017;14(5):351-364. DOI: 10.1007/s11897-017-0348-6

Bradley TD, Floras JS. Sleep apnea and heart failure: Part II: central sleep apnea. Circulation. 2003;107(13):1822-6. DOI: 10.1161/01.CIR.0000061758.05044.64

Cowie MR, Gallagher AM. Sleep Disordered Breathing and Heart Failure: What Does the Future Hold? JACC Heart Fail. 2017;5(10):715-723. DOI: 10.1016/j.jchf.2017.06.016.

Costanzo MR, Khayat R, Ponikowski P, Augostini R, Stellbrink C, Mianulli M, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure. J Am Coll Cardiol. 2015;65(1):72-84. DOI: 10.1016/j.jacc.2014.10.025

Eckert DJ, Jordan AS, Merchia P, Malhotra A. Central sleep apnea: Pathophysiology and treatment. Chest. 2007;131(2):595-607. DOI: 10.1378/chest.06.2287

Беграмбекова Ю.Л., Каранадзе Н.А., Орлова Я.А. Нарушения системы дыхания при хронической сердечной недостаточности. Кардиология. 2019;59(2S):15-24. DOI: 10.18087/cardio.2626

Giannoni A, Emdin M, Poletti R, Bramanti F, Prontera C, Piep-oli M, et al. Clinical significance of chemosensitivity in chronic heart failure: influence on neurohormonal derangement, Cheyne-Stokes respiration and arrhythmias. Clin Sci (Lond). 2008;114(7):489-97. DOI: 10.1042/CS20070292

Ponikowski P, Banasiak W. Chemosensitivity in chronic heart failure. Heart Fail Monit. 2001;1(4):126-31. PMID: 12634897.

Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Ba-nasiak W, et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation. 2001;104(5):544-9. DOI: 10.1161/hc3101.093699

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. Erratum in: Eur Heart J. 2016. PMID: 27206819.

Pinna GD, Maestri R, Mortara A, La Rovere MT. Cardiorespiratory interactions during periodic breathing in awake chronic heart failure patients. Am J Physiol Heart Circ Physiol. 2000;278(3):H932-41. DOI: 10.1152/ajpheart.2000.278.3.H932

Sateia MJ. International classification of sleep disor-ders-third edition: highlights and modifications. Chest. 2014;146(5):1387-1394. DOI: 10.1378/chest.14-0970

Terziyski K, Draganova A. Central Sleep Apnea with Cheyne-Stokes Breathing in Heart Failure - From Research to Clinical Practice and Beyond. Adv Exp Med Biol. 2018;1067:327-351. DOI: 10.1007/5584_2018_146

Perger E, Inami T, Lyons OD, Alshaer H, Smith S, Floras JS, et al. Distinct Patterns of Hyperpnea During Cheyne-Stokes Respiration: Implication for Cardiac Function in Patients With Heart Failure. J Clin Sleep Med. 2017;13(11):1235-1241. DOI: 10.5664/jcsm.6788. Erratum in: J Clin Sleep Med. 2018;14(4):703.

Javaheri S, Blackwell T, Ancoli-Israel S, Ensrud KE, Stone KL, Redline S; et al. Sleep-disordered Breathing and Incident Heart Failure in Older Men. Am J Respir Crit Care Med. 2016;193(5):561-8. DOI: 10.1164/rccm.201503-0536OC

Martinot JB, Borel JC, Le-Dong NN, Guenard HJ, Cuthbert V, Silkoff PE, et al. Monitoring mandibular movements to detect Cheyne-Stokes Breathing. Respir Res. 2017;18(1):66. DOI: 10.1186/s12931-017-0551-8

Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U, et al. Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J. 2016;37(21):1695-703. DOI: 10.1093/eurheartj/ehv624

Walsh JT, Andrews R, Starling R, Cowley AJ, Johnston ID, Kinnear WJ. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J. 1995;73(3):237-41. DOI: 10.1136/hrt.73.3.237

Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest. 2007;131(1):130-5. DOI: 10.1378/chest.06-0919

MacDonald M, Fang J, Pittman SD, White DP, Malhotra A. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med. 2008;4(1):38-42. PMID: 18350960; PMCID: PMC2276820.

Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med. 2006;173(2):234-7. DOI: 10.1164/rccm.200507-1035OC

Schmickl CN, Landry SA, Orr JE, Chin K, Murase K, Ver-braecken J, et al. Acetazolamide for OSA and Central Sleep Apnea: A Comprehensive Systematic Review and MetaAnalysis. Chest. 2020;158(6):2632-2645. DOI: 10.1016/j.chest.2020.06.078

Jaffuel D, Molinari N, Berdague P, Pathak A, Galinier M, Dupuis M, et al. Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design. ESC Heart Fail. 2018;5(3):222-230. DOI: 10.1002/ehf2.12270.

Bitter T, Westerheide N, Hossain SM, Prinz C, Horstkotte D, Oldenburg O. Symptoms of sleep apnoea in chronic heart failure-results from a prospective cohort study in 1,500 patients. Sleep Breath. 2012;16(3):781-91. DOI: 10.1007/s11325-011-0575-0

Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9(3):251-7. DOI: 10.1016/j.ejheart.2006.08.003

Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace. 2011;13(8):1174-9. DOI: 10.1093/europace/eur128

White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med. 2005;172(11):1363-70. DOI: 10.1164/rccm.200412-1631SO

Floras JS, Bradley TD. Atrial overdrive pacing for sleep apnea: a door now closed? Am J Respir Crit Care Med. 2005;172(1):1-3. DOI: 10.1164/rccm.2503007

Bradley TD, Logan AG, Floras JS; CANPAP Investigators. Rationale and design of the Canadian Continuous Positive Airway Pressure Trial for Congestive Heart Failure patients with Central Sleep Apnea--CANPAP. Can J Cardiol. 2001;17(6):677-84. PMID: 11420579.

Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353(19):2025-33. DOI: 10.1056/NEJMoa051001

Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25):3173-80. DOI: 10.1161/CIRCULATIONAHA.106.683482

Huseini T, McArdle N, Jasper E, Kurmagadda S, Douglas J, King S, et al. The use and effectiveness of adaptive servo ventilation in central sleep apnea: a study of consecutive sleep clinic patients. J Sleep Res. 2020;29(4):e13016. DOI: 10.1111/jsr.13016

Javaheri S, Germany R, Greer JJ. Novel Therapies for the Treatment of Central Sleep Apnea. Sleep Med Clin. 2016;11(2):227-39. DOI: 10.1016/j.jsmc.2016.01.004

Somers V, Arzt M, Bradley TD, Randerath W, Tamisier R, Won C. Servo-Ventilation Therapy for Sleep-Disordered Breathing. Chest. 2018;153(6):1501-1502. DOI: 10.1016/j.chest.2018.03.052

Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med. 2015;373(12):1095-105. DOI: 10.1056/NEJMoa1506459

McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med. 2016;375(10):919-31. DOI: 10.1056/NEJMoa1606599

Woehrle H, Cowie MR, Eulenburg C, Suling A, Angermann C, d'Ortho MP, et al. Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis. Eur Respir J. 2017;50(2):1601692. DOI: 10.1183/13993003.01692-2016

Калинкин А. Л., Шестопалова И.М., Ардашев А.В., Бертова О.Н., Кузовлев О.П. Дыхание Чейн-Стокса во время сна как маска обострения ИБС. Диагностика и лечение методом адаптивной сервовентиляции. Клиническая практика. 2014;(1):26-30.DOI: 10.17816/clinpract5126-30

Holt A, Bjerre J, Zareini B, Koch H, T0nnesen P, Gislason GH, et al. Sleep Apnea, the Risk of Developing Heart Failure, and Potential Benefits of Continuous Positive Airway Pressure (CPAP) Therapy. J Am Heart Assoc. 2018;7(13):e008684. DOI: 10.1161/JAHA.118.008684

Augostini RS, Afzal MR, Costanzo MR, Westlund R, Stellbrink C, Gutleben K, et al. How to implant a phrenic nerve stimulator for treatment of central sleep apnea? J Cardiovasc Electrophysiol. 2019;30(5):792-799. DOI: 10.1111/jce.13898

Costanzo MR, Augostini R, Goldberg LR, Ponikowski P, Stellbrink C, Javaheri S. Design of the remede System Pivotal Trial: A Prospective, Randomized Study in the Use of Respiratory Rhythm Management to Treat Central Sleep Apnea. J Card Fail. 2015;21(11):892-902. DOI: 10.1016/j.card-fail.2015.08.344

Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail. 2018;20(12):1746-1754. DOI: 10.1002/ejhf.1312

Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg LR, Holcomb R, et al. Sustained 12 Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea. Am J Cardiol. 2018;121(11):1400-1408. DOI: 10.1016/j.amj-card.2018.02.022

Fox H, Oldenburg O, Javaheri S, Ponikowski P, Augostini R, Goldberg LR, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep. 2019;42(11):zsz158. DOI: 10.1093/sleep/zsz158

Fudim M, Spector AR, Costanzo MR, Pokorney SD, Mentz RJ, Jagielski D, et al. Phrenic Nerve Stimulation for the Treatment of Central Sleep Apnea: A Pooled Cohort Analysis. J Clin Sleep Med. 2019;15(12):1747-1755. DOI: 10.5664/jcsm.8076

Jagielski D, Ponikowski P, Augostini R, Kolodziej A, Khayat R, Abraham WT. Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months' experience with the remede® System. Eur J Heart Fail. 2016;18(11):1386-1393. DOI: 10.1002/ejhf.593

Gutleben KJ, Fox H, Sommer P, Rudolph V, Nolker G. Interventional techniques to increase implantation success of transvenous phrenic nerve stimulation for central sleep apnea treatment. Sleep Breath. 2020;24(3):905-912. DOI: 10.1007/s11325-019-01917-0

Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A, et al. Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail. 2015;3(5):360-369. DOI: 10.1016/j.jchf.2014.12.013

The authors declare that there are no conflicts of interest present.